CD36: a key mediator of resistance to HER2 inhibitors in breast cancer.

Feng, William W; Bang, Scott; Kurokawa, Manabu

Feng, William W; Bang, Scott; Kurokawa, Manabu.

Afiliação

Feng WW; Department of Biological Sciences, Kent State University, Kent, OH, USA.
Bang S; Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Kurokawa M; Department of Biological Sciences, Kent State University, Kent, OH, USA.

Mol Cell Oncol ; 7(2): 1715766, 2020.

Article em En | MEDLINE | ID: mdl-32158927

Palavras-chave

FASN; FATP; lapatinib; lipid metabolism; trastuzumab

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051136
https://dx.doi.org/10.1080/23723556.2020.1715766

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051136
https://dx.doi.org/10.1080/23723556.2020.1715766

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article